Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer
Journal of Women's Health · 2024
DOI: 10.1089/jwh.2023.0971 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Jingjing Qian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Auburn University Harrison College of Pharmacy, Auburn, Alabama, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Hormonal, SEER Program, Medicare. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Auburn University Harrison College of Pharmacy, Auburn, Alabama, USA.
Zitieren
APA
Qian, J., & Truong, B. (2024). Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.0971
Vancouver
Qian J, Truong B. Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer. Journal of Women's Health. 2024. doi:10.1089/jwh.2023.0971
BibTeX
@article{Qian2024,
author = {Qian, Jingjing and Truong, Bang},
title = {Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer},
journal = {Journal of Women's Health},
year = {2024},
doi = {10.1089/jwh.2023.0971}
}
EUVIMED